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1. Introduction
  Ischemic stroke, also called ischemic cerelral infarction, 
belongs to the category of “stroke” in traditional Chinese 
medicine. It is a kind of common ailment and frequently 
encountered disease with the characteristic of high mortality 
and disability rate[1-3]. Ischemic stroke has become one of 
the most detrimental diseases. Traditional Chinese medicine 
has showed unique academic advantage in the prevention 
and cure of stroke. 
  Zhong-Ying Zhou, a expert in Chinese medicine, put 
forward the etiology and pathogenesis theory of “stagnant 
heat” on the basis of the ancients’ diagnosis and treatment 
theory and decades of clinical practice experience. 
Professor Zhou considers that ischemic stroke is similar to 
many troublesome diseases of internal Chinese medicine. 
In the process of ischemic stroke, the blood heat and blood 
stasis exist simultaneously. The effect will be poor if the 
therapy of removing heat to cool blood or promoting blood 
to remove stasis is used alone. Over the years, Zhou et al 
has used the therapy of cooling blood to remove stasis with 
the theory of “stasis hot”, and has achieved remarkable 
curative effect[4,5]. Liangxuehuayu Recipe is the empirical 
recipe for ischemic stroke formulated by Zhou on the basis 
of the characteristic of “stasis hot” in ischemic stroke. In 
this study, we observed the effects of Liangxuehuayu Recipe 
on hemorheology in rats with blood stasis syndrome, and 
provided experimental basis for clinical application of this 
formula.
Objective: To investigate the effects of Liangxuehuayu Recipe on hemorheology in rats with 
blood stasis syndrome induced by mutifactor stimuli. Methods: SD rats were divided into control, 
model, Liangxuehuayu Recipe (high, middle and low dose, 18, 9, 4.5 g/kg accordingly). Except 
the control group, blood stasis model was established in the rest groups. The hemorheological 
parameters were measured and compared. Results: Blood viscosity at high, moderate and 
low level in rats with blood stasis significantly increased (P<0.05), but blood viscosity at high 
level and plasma viscosity was significantly decreased in rats induced by some stimuli after 
Liangxuehuayu Recipe were intra-gastrically administered for 1 weeks (P<0.01, P<0.05). 
Conclusions: Liangxuehuayu Recipe is effective in improving hemorheology, and has important 
application value in the prevention of occurrence and development of ischemic stroke.
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2. Materials and methods
2.1.  Drugs and reagent
  Liangxuehuayu Recipe, which was processed by the 
center of plant medicine research and development of new 
medicine, is brown liquid with the batch number of 06011. 
Mailuoning injection, Nanjing Jinling pharmaceutical 
factory, Jinling pharmaceutical Co., Ltd, the batch number: 
20060106. Activated partial thromboplastin time (APTT) 
reagent kit, Beijing Shidi Scientific Instruments Company, 
the batch number: ST20202-23. Fibrinogen (FIB) reagent 
kit, Beijing Shidi Scientific Instruments Company, the 
batch number: ST20401-21. Prothrombin time (PT) reagent 
kit, Beijing Shidi Scientific Instruments Company, the 
batch number: ST20102-29. Thrombin time (TT) reagent 
kit, Beijing Shidi Scientific Instruments Company, the 
batch number: ST20302-22. NOS ELISA reagent kit, ADL 
Company of the United States, the batch number: 08-10. 
Adenosine diphosphate glucose pyrophospheralase (ADP), 
Sigma Company, the batch number: A-2754. Chloralic 
hydras, A.R, the Chinese Medicine Group Chemical Reagent 
Co., Ltd, the batch number: 20050525. 0.9% NaCl injection, 
Nanjing Xiaoying pharmaceutical Co., Ltd, he batch number: 
2005102904.
2.2.  Experimental animals
  Male SD rats in a SPF grade with the weight of 300-400 g 
which supplied by Shanghai Silaike Experimental Animal 
Liability Co., Ltd. were selected. The certificate number is 
SCXK(Shanghai)-2003-0003.
2.3.  Instruments
Electrothermal constant-temperature dry box of DHG-9053 
A type, Shanghai Medical Thermostatic Equipment Factory. 
Blood viscosity meter of LG-R-80 series, Beijing Shidi 
Scientific Instruments Company.
2.4.  Experimental methods
  Male SD rats with qualified temperature were divided into 
6 groups randomly, control group, model group, positive 
medicine group (Fufangdanshen tablets, 1.08 g/kg), high, 
middle, low dose group (Liangxuehuayu Recipe, 18 g/
kg, 9 g/kg, 4.5 g/kg, dry, the same below). The 6 groups 
received continuous dosing for 6 days, Until 1 h after final 
dose, except for the control group, the acute blood stasis 
models in the other groups were established according to 
the references[3]: 0.1% adrenergic 0.8 mL/kg, subcutaneous 
injection, after 2 h, the rats received cold stimulation in ice 
water for 5 min, and then an injection of equal amount of 
adrenergic was carried out. 10% chloralic hydras (300 mg/kg, 
i.p.) was used for fixing rats in the overhead position 1 h after 
dosing at the second day. The blood collection was carried 
out by carotid artery intubation, and the anticoagulation was 
carried out at the ratio of 1:9 with 3.8% sodium citrate. The 
whole blood viscosity, plasma viscosity, blood coagulation 
time were detected by automatic hemarheology meter.
2.5.  Statistical processing
  All the data were analyzed by SPSS 17.0. The measurement 
data were expressed as mean 依 standard deviation, and 
one-way analysis of variance (ANOVA) was used. P<0.05 was 
defined as having statistical difference.
3. Results  
  As Table 1, 2 and 3 show, high dose of Liangxuehuayu 
Recipe can obviously reduce the platelet aggregation 
rate, prolong PT and reduce the content of FIB, it can also 
enhance the defomation ability of red blood cell, weaken the 
aggregation ability of red blood cell. In middle and low shear 
rates, the high dose can reduce the whole blood viscosity 
and plasma viscosity, The difference reached statistical 
significance compared with the model group (P<0.05, 
P<0.01). The middle dose of Liangxuehuayu Recipe can 
enhance the defomation ability of red blood cell, weaken the 
Table 1
Influence of Liangxuehuayu Recipe on platelet aggregation rate(n=10, x依SD).
Group Dose (g/kg) Platelet aggregation rate (%) Aggregation inhibition rate(%)
Control group -   26.67依7.41* -
Model group -  34.02依6.68 -
Fufangdanshen group   8   28.06依5.98* 17.52
Low dose group      4.5 33.28依8.53   2.18
Middle dose group   9   28.58依14.68 16.00
High dose group 18  28.12依5.83* 17.34
*P<0.05 vs. control group.
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aggregation ability of red blood cell. The difference reached 
statistical significance compared with the model group 
(P<0.05, P<0.01).
4. Discussion
  Blood stasis syndrome refers to the patho-physiological 
state of blood stagnation, delayed blood flow, blockade 
in blood vessel, and is one of the most common clinical 
syndromes. Professor Zhou indicated that stasis includes 
blood stasis and static blood in the state of “stagnant heat”. 
Blood stasis refers to the delayed and impeded blood flow, 
local stagnation, while the static blood refers to a kind of 
pathological product, both can be reciprocal causation. 
Previous study[4,5] revealed that the “stasis” in traditional 
Chinese medicine was closely related to the dysfunction of 
blood system. The dysfunction of blood system was also the 
basis of pathology and pathological performance of ischemic 
stroke. The patients with ischemic stroke usually showed 
the characteristic of “blood stasis” of pre-thrombosis or 
thrombosis state. Therefore, improvement of abnormal 
hemarheology, is the common therapeutic principle for 
traditional Chinese medicine and western medicine in the 
treatment of ischemia stroke.
  Liangxuehuayu Recipe consists of cortex moutan, radix 
raeoniae rubra, acorus gramineus, cornu bubali and 
rhubarb. It’s a basic recipe for the treatment of ischemia 
stroke according to the theory of “stagnant heat”. The 
cortex moutan and radix raeoniae rubra have the effect of 
cooling, activating blood and scattering stasis[6,7]. Total 
paeony glycoside, the key ingredient of radix raeoniae rubra, 
can prolong the cogulation time, inhibit the formation of 
thrombus. Paeonol, the key ingredient of cortex moutan, 
has been proved to be the calcium channel blocker, and 
has the spasmolysis for vascular smooth muscle and the 
effect of anti-free radical, analgesia, sedation and anti-
convulsion[8]. Therefore, it has important significance in the 
prevention and control of ischemic brain damage. Cornu 
bubali and rhubarb have the effect of removing heat to cool 
blood, with the complementary of the two drugs, the function 
of cooling blood to remove stasis will be more effective[9-11]. 
Chinese scholars have carried out a series of studies on the 
therapy of traditional Chinese medicine on hemorheology 
in rats with blood stasis syndrome[12-16]. Zhao et al[17]
explored the effect of the effective components group of 
Xiaoshuantongluo formula (XECG) on acute blood stasis rat 
model, the results showed that XECG significantly reduced 
ADP-induced platelet aggregation, but little influence on 
the whole blood viscosity, plasma viscosity and erythrocyte 
aggregation rate. XECG extended PT and TT slightly, but 
had no effects on APTT and FIB content. The results suggest 
that the role of XECG of anti-aggregation is more prominent. 
Deng et al[18] established a rat model of blood stasis and heat 
accumulation syndrome in accordance with the traditional 
Chinese medicine theoretic features. The results showed that 
compared with the model group, the length of ecchymosis 
in the tail obviously decreased in rats of the danshen root 
group, the blood velocity score of the microcirculation 
obviously increased, the whole blood viscosity, hematocrit, 
Table 2
Influence of Liangxuehuayu Recipe on defomation and aggregation ability of red blood cell (n=10, x依SD).
Group Dose (g/kg)
Defomation ability Aggregation ability
MAXDI SSS MAXD SS
Control group -  0.50依0.03*  250.1依15.7*  0.80依0.37*   142.7依39.9**
Model group - 0.46依0.04 230.0依19.2 1.33依0.50 226.1依72.3
Fufangdanshen group   8  0.51依0.04*  251.3依18.0*  0.82依0.37*  158.9依49.7*
Low dose group     4.5 0.50依0.05  248.4依14.6* 1.13依0.59 185.8依54.5
Middle dose group   9   0.52依0.02**   258.6依14.9**  0.93依0.25* 181.3依39.0
High dose group 18  0.53依0.07* 260.5依28.8*  0.82依0.28*  164.8依43.1*
*P<0.05, **P<0.01 vs. control group.
Table 3












Control group - 5.60依1.16   7.24依1.79*   12.9依3.6*  28.1依9.9*  1.44依0.28*
Model group - 6.68依1.20  9.19依1.63  16.6依3.7   37.7依10.1 2.09依0.70
Fufangdanshen group   8  5.62依0.92*   7.25依1.50*   12.9依3.5*  27.1依9.6*  1.51依0.41*
Low dose group     4.5 6.46依1.65 8.40依2.38 15.7依3.9 39.1依9.3 1.86依0.51
Middle dose group   9 6.35依0.94 8.12依1.40 14.8依5.0   33.0依11.9 1.82依0.64
High dose group 18 5.95依0.96  7.41依1.56*  12.3依3.0*  27.6依7.5*   1.57依0.26*
*P<0.05, **P<0.01 vs. control group.
Song-Yi Ning et al./Asian Pacific Journal of Tropical Medicine (2012)935-938938
and erythrocyte electrophoretic time obviously decreased, 
red blood cell deformation index obviously increased.
  The results of this study shows that after the intervention 
of Liangxuehuayu Recipe, the abnormal hemorheology 
which caused by compound factors improved obviously: 
the obvious reduction of whole blood viscosity and plasma 
viscosity in low and middle shear rates, and can also 
enhance the defomation ability of red blood cell, weaken 
the aggregation ability of red blood cell, and improve 
coagulation function. 
  In conclusion, Liangxuehuayu Recipe can play the role of 
treatment according to the main pathological characteristics 
of blood stasis, and its effect of improving hemorheology has 
important application value in the prevention of occurrence 
and development of ischemic stroke. 
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